Site icon pharmaceutical daily

Bacterial Vaginosis – Pipeline Review, H1 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Bacterial
Vaginosis – Pipeline Review, H1 2019”
drug pipelines has been
added to ResearchAndMarkets.com’s offering.

Bacterial Vaginosis – Pipeline Review, H1 2019 provides
comprehensive information on the therapeutics under development for
Bacterial Vaginosis (Infectious Disease), complete with analysis by
stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest
news and press releases. The Bacterial Vaginosis (Infectious Disease)
pipeline guide also reviews of key players involved in therapeutic
development for Bacterial Vaginosis and features dormant and
discontinued projects.

The guide covers therapeutics under Development by
Companies/Universities/Institutes, the molecules developed by Companies
in Pre-Registration, Phase II, Phase I and Preclinical stages are 1, 6,
1 and 3 respectively. Similarly, the Universities portfolio in Discovery
stages comprises 1 molecule, respectively.

Bacterial Vaginosis (Infectious Disease) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Scope

Reasons to Buy

Featured News & Press Releases

Companies Mentioned

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/7gi859

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs

Exit mobile version